Integrated Quantitative Investments’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-24,302
Closed -$241K 354
2025
Q2
$241K Buy
+24,302
New +$238K 0.07% 344

Other funds holding ANGO

Integrated Quantitative Investments's ANGO Position: Q3 2025 in Review

Integrated Quantitative Investments sold out of AngioDynamics (ANGO) in Q3 2025, closing a stake of 24,302 shares — an estimated $241K sold.

Integrated Quantitative Investments first reported a position in ANGO in Q2 2025 and held it in 1 quarter. The position peaked at $241K in Q2 2025. 144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.

  • Integrated Quantitative Investments reported no remaining AngioDynamics position as of Q3 2025 after selling out during the quarter.
  • Integrated Quantitative Investments sold 24,302 AngioDynamics shares in Q3 2025, an estimated $241K.
  • Integrated Quantitative Investments first reported a position in AngioDynamics in Q2 2025 and held it in 1 quarter.
  • Integrated Quantitative Investments's AngioDynamics position peaked at $241K in Q2 2025.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.

Based on Integrated Quantitative Investments's 13F filing for Q3 2025, filed 12 Nov 2025.